Advertisement

Topics

With new data at hand, Novartis to file for canakinumab heart indication this year

06:59 EST 14 Nov 2017 | thePharmaLetter

In addition to a wealth of previous data, Swiss pharma giant Novartis has now published a new analysts…

Original Article: With new data at hand, Novartis to file for canakinumab heart indication this year

NEXT ARTICLE

More From BioPortfolio on "With new data at hand, Novartis to file for canakinumab heart indication this year"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...